Job Description

Opportunity

Cedars-Sinai Health System seeks a collaborative and strategic leader to serve as the next Department of Radiation

Oncology Chair. The chair will fill a key executive role at nationally-ranked Cedars-Sinai. This is an outstanding opportunity for an accomplished clinical leader to oversee innovation and the highest quality clinical care across Cedars-Sinai. The chair will direct all facets of the department, ensuring that the overall strategic vision and direction aligns with the broader Cedars-Sinai mission. The chair will achieve success by providing expert leadership in the following areas:

• Strategic, operational and fiscal oversight. The chair manages all aspects of the department, including administrative, clinical, research, and educational initiatives, managing a complex departmental budget, optimizing throughput at satellite locations, and ensuring revenue growth through efficient resource utilization and business development.
• Clinical innovation and subspecialized expertise. The chair ensures the continuous evolution of clinical practice, driving the adoption and integration of next-generation therapeutic modalities and imaging technologies that redefine the standard of care for complex and rare pathologies and positions the department at the forefront of precision medicine.
• Patient care and quality improvement. A key focus is on ensuring excellent patient care. The chair will uphold prestigious APEx accreditation through quality standards by fostering a proactive culture of multidisciplinary peer-review, patient safety, quality improvement, and risk management by linking them to evidence-based medicine.
• Research distinction and extramural funding. The chair will define a strategic research vision that accelerates scholarly output, enhances clinical trial enrollment, increases extra-mural and federal award funding, and translates laboratory discoveries into investigator-initiated clinical trials.
• Education and training. The chair will also have operational oversight of training programs, ensuring excellence in training and education leading the delivery of premier graduate medical education and residency training.
• Faculty mentorship and development. The chair is responsible for attracting, mentoring, and developing both clinical and research-focused faculty. They provide guidance to junior faculty members to create a strong, robust department.
• Multidisciplinary collaboration. The chair is the primary driver in integrating and coordinating radiation oncology services across departments and service lines to provide seamless, evidence-based care within the Samuel Oschin Comprehensive Cancer Institute.

Cedars-Sinai Radiation Oncology

As a cornerstone of Cedars-Sinai Cancer, the Department of Radiation Oncology is a hub of clinical innovation and compassionate care in the heart of Los Angeles. The department serves a diverse patient population, offering the Chair an opportunity to lead a multidisciplinary team of world-renowned radiation oncologists, physicists, and researchers. The incoming Chair will assume leadership of a department with a thriving culture characterized by clinical excellence and multidisciplinary collaboration. Faculty work in close partnership with surgical and medical oncology colleagues to provide excellent integrated care.

Subspecialized Expertise

The Department of Radiation Oncology at Cedars-Sinai, which includes 28 faculty and 117 staff, is recognized for its high-volume, academic-driven approach, holding the prestigious APEx accreditation from the American Society for Radiation Oncology (ASTRO). Building on a foundation of ultra-precise technology and site-specific clinical mastery, our new chair will identify areas of clinical excellence and implement cutting-edge services and technologies.

Innovation and Research

The Department of Radiation Oncology at Cedars-Sinai is committed to redefining the standard of care through the development of next-generation imaging and therapeutic modalities. By integrating cutting-edge research across our Divisions of Medical Physics and Radiation Biology, we aim to enhance therapeutic efficacy while minimizing off-target toxicity. Our program leverages AI-driven computational models and precision medicine frameworks to translate laboratory discoveries into investigator-initiated clinical trials, ensuring that advanced, site-specific therapies are delivered with unprecedented accuracy and biological optimized dosing.

• For Fiscal Year 2025 (FY25), the department successfully enrolled 37 patients into clinical protocols led by Radiation Oncology Principal Investigators.
• The program maintains an active portfolio of investigator-initiated and cooperative group trials, spanning diverse disease sites including genitourinary (GU), head and neck, lymphoma, and myeloma.
• Research efforts remain centered on the advancement of biomarker-driven precision medicine and therapeutic de-intensification strategies aimed at optimizing patient survival and quality of life.

The department has an excellent track record of external funding and academic productivity. Reflecting a robust commitment to academic dissemination, we aim to continue our upward trajectory in research quality and output. Our FY25 academic accomplishments include:

• Federal Award Funding: $2,524,117
• Total Award Funding: $3,012,117
• In FY25, our department has produced 42 total publications, reflecting a robust commitment to academic dissemination.
• Our program has demonstrated an upward trajectory in research quality, with 21 publications appearing in journals with an Impact Factor (IF) greater than 10-an increase from the 20 high-impact publications recorded in FY24.
• Faculty have achieved consistent placement in top-tier medical literature, including multiple contributions to the Journal of Clinical Oncology.

Quality

The Department of Radiation Oncology at Cedars-Sinai upholds a rigorous commitment to patient safety and therapeutic excellence, underscored by its prestigious APEx (Accreditation Program for Excellence) designation from the American Society for Radiation Oncology (ASTRO). This accreditation validates the department's adherence to over 200 stringent quality standards, encompassing exhaustive staff training, rigorous equipment maintenance, and standardized clinical documentation. To operationalize a proactive culture of safety, the department has implemented more than 60 specialized policies designed to ensure that every patient receives a personalized, evidence-based treatment plan verified through multidisciplinary peer-review protocols. By integrating sophisticated image-guided technologies and continuous real-time monitoring, the clinical team-comprising radiation oncologists, medical physicists, and therapists-ensures the precise delivery of radiation while meticulously sparing adjacent healthy tissue. This systematic approach to quality assurance is reflected in the department's high clinical benchmarks and superior patient satisfaction ratings.

Locations

• Main Campus Capital Enhancements: A significant expansion of the main campus is scheduled for completion in 2028, which will introduce a fourth treatment vault, a new linear accelerator, and an MR simulator. This expansion further includes augmented examination facilities and a dedicated inpatient holding suite to enhance clinical workflow.
• Throughput Optimization (Tarzana): The Tarzana site is currently under evaluation for expansion to mitigate throughput bottlenecks following a substantial increase in patient volume, which rose from approximately 15 daily encounters in 2021 to over 40 per day in 2025.
• Regional Integration (Huntington Hospital): The modernization program at Huntington Hospital involves the planned implementation of a Varian TrueBeam platform, with a projected clinical "go-live" date in 2026.